SYNAPSET Trademark

Trademark Overview


On Sunday, April 30, 2017, a trademark application was filed for SYNAPSET with the United States Patent and Trademark Office. The USPTO has given the SYNAPSET trademark a serial number of 87431283. The federal status of this trademark filing is CANCELLATION TERMINATED - SEE TTAB RECORDS as of Tuesday, August 20, 2019. This trademark is owned by Bioflash inc. The SYNAPSET trademark is filed in the Pharmaceutical Products category with the following description:

Beverages containing fish oils, minerals, vitamins, for use as a nutritional supplement; Chemical preparations for pharmaceutical or medical purposes, namely, for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of nutritional supplements; Dietary and nutritional supplements; Dietary and nutritional supplements containing fish oils, minerals, vitamins, plant oil; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplement beverage for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietary supplement drink mix...
synapset

General Information


Serial Number87431283
Word MarkSYNAPSET
Filing DateSunday, April 30, 2017
Status780 - CANCELLATION TERMINATED - SEE TTAB RECORDS
Status DateTuesday, August 20, 2019
Registration Number5558464
Registration DateTuesday, September 11, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2018

Trademark Statements


Goods and ServicesBeverages containing fish oils, minerals, vitamins, for use as a nutritional supplement; Chemical preparations for pharmaceutical or medical purposes, namely, for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of nutritional supplements; Dietary and nutritional supplements; Dietary and nutritional supplements containing fish oils, minerals, vitamins, plant oil; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplement beverage for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietary supplement drink mixes; Dietary supplemental drinks; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements; Dietary supplements also containing minerals, vitamins, oils; Dietary supplements for human consumption; Dietary supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Dietetic foods for treating attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Edible fish oils, mineral preparations, vitamins, and medicinal plant oils adapted for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of pharmaceutical preparations; Edible fish oils for medical purposes; Food supplements; Food supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Gummy vitamins; Liquid nutritional supplement; Liquid vitamin supplements; Medicaments for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson 's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Medicated water for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Medicinal drinks; Migraine treatment preparations; Mineral food supplements; Mineral nutritional supplements; Mineral supplements; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Mixed vitamin preparations; Multi-vitamin preparations; Multivitamin preparations; Natural dietary supplements; Natural dietary supplements for the treatment of attentiondeficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Natural supplements for treating depression and anxiety; Nutraceuticals for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplement energy bars; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements consisting primarily of Omega3 oil, vitamins, vitamin B6, minerals, zinc, magnesium; Nutritional supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutritional supplements in the form of powder, liquid, capsules, tablets, gel; Nutritional supplements, namely, probiotic compositions; Nutritionally fortified beverages for medical purposes; Nutritionally fortified water for medical purposes; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment and prevention of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Pharmaceutical preparations for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Pharmaceutical preparations for treating chemical imbalances; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Powdered nutritional supplement drink mix containing fish oils, vitamins, minerals, plant oils; Therapeutic pharmaceutical for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Vitamin and mineral supplements for mixing with food and beverages; Vitamin B preparations; Vitamin fortified beverages for medical purposes; Vitamin preparations; Vitamin supplements; Vitamin tablets; Vitamins; Vitamins and vitamin preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioflash inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSherbrooke
CA

Party NameBioflash inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSherbrooke
CA

Party NameBioflash inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSherbrooke
CA

Trademark Events


Event DateEvent Description
Monday, September 11, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 20, 2019TTAB RELEASE CASE TO TRADEMARKS
Tuesday, August 20, 2019CANCELLATION TERMINATED NO. 999999
Tuesday, August 20, 2019CANCELLATION DENIED NO. 999999
Monday, October 1, 2018CANCELLATION INSTITUTED NO. 999999
Tuesday, September 11, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, June 26, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 6, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 23, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, May 18, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, May 14, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 18, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 14, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 16, 2018NON-FINAL ACTION E-MAILED
Friday, March 16, 2018NON-FINAL ACTION WRITTEN
Friday, March 16, 2018NON-FINAL ACTION WRITTEN
Friday, March 16, 2018REMOVED FROM TEAS PLUS
Monday, March 5, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 28, 2018ASSIGNED TO LIE
Friday, February 16, 2018NOTICE OF REVIVAL - E-MAILED
Thursday, February 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 15, 2018PETITION TO REVIVE-GRANTED
Thursday, February 15, 2018TEAS PETITION TO REVIVE RECEIVED
Thursday, August 3, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, August 3, 2017PRIORITY ACTION E-MAILED
Thursday, August 3, 2017PRIORITY ACTION WRITTEN
Thursday, July 27, 2017ASSIGNED TO EXAMINER
Friday, May 5, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 3, 2017NEW APPLICATION ENTERED